Literature DB >> 32413341

Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health.

Mohammed Eslam1, Jian-Gao Fan2, Nahum Mendez-Sanchez3.   

Abstract

Entities:  

Year:  2020        PMID： 32413341     DOI： 10.1016/S2468-1253(20)30090-X

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  13 in total

1.  The metabolic profiles and body composition of lean metabolic associated fatty liver disease.

Authors:  Yu-Ming Cheng; Jia-Horng Kao; Chia-Chi Wang
Journal:  Hepatol Int       Date:  2021-02-04       Impact factor: 6.047

Review 2.  Detangling the interrelations between MAFLD, insulin resistance, and key hormones.

Authors:  Shreya C Pal; Mohammed Eslam; Nahum Mendez-Sanchez
Journal:  Hormones (Athens)       Date:  2022-08-03       Impact factor: 3.419

3.  Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study.

Authors:  Aruhan Yang; Xiaoxue Zhu; Lei Zhang; Yingwen Zhang; Dezhi Zhang; Meishan Jin; Junqi Niu; Huimao Zhang; Yanhua Ding; Guoyue Lv
Journal:  Hepatol Int       Date:  2022-07-12       Impact factor: 9.029

Review 4.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

5.  Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease.

Authors:  Jing Zheng; Huizhong Wu; Zhiying Zhang; Songqiang Yao
Journal:  Hereditas       Date:  2021-08-21       Impact factor: 3.271

Review 6.  Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases.

Authors:  Winston Hernández-Ceballos; Jacqueline Cordova-Gallardo; Nahum Mendez-Sanchez
Journal:  J Clin Transl Hepatol       Date:  2021-03-08

7.  GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity.

Authors:  Yumeng Peng; Qiang Zeng; Luming Wan; Enhao Ma; Huilong Li; Xiaopan Yang; Yanhong Zhang; Linfei Huang; Haotian Lin; Jiangyue Feng; Yixin Xu; Jingfei Li; Muyi Liu; Jing Liu; Changqin Lin; Zhiwei Sun; Gong Cheng; Xuemiao Zhang; Jialong Liu; Dongrui Li; Meng Wei; Yunhai Mo; Xuetao Mu; Xiaowei Deng; Dandan Zhang; Siqing Dong; Hanqing Huang; Yi Fang; Qi Gao; Xiaoli Yang; Feixiang Wu; Hui Zhong; Congwen Wei
Journal:  Nat Commun       Date:  2021-12-01       Impact factor: 14.919

8.  Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity.

Authors:  Zi-Xuan Wang; Meng-Yu Wang; Rui-Xu Yang; Ze-Hua Zhao; Feng-Zhi Xin; Yu Li; Tian-Yi Ren; Jian-Gao Fan
Journal:  Front Nutr       Date:  2022-03-17

9.  Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).

Authors:  Nahum Méndez-Sánchez; Luis Enrique Díaz-Orozco
Journal:  Med Sci Monit       Date:  2021-07-12

10.  MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis.

Authors:  Jiaofeng Huang; Wenjuan Xue; Mingfang Wang; Yinlian Wu; Medha Singh; Yueyong Zhu; Rahul Kumar; Su Lin
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-27       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.